The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

For patients with heart failure, a reduced ejection fraction, and an indication for cardiac resynchronization therapy (CRT), using His-Purkinje conduction system pacing (HPCSP) is safe and feasible ...

Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...

The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...

BOSTON -- Lead wires implanted for conduction system pacing have thus far been feasible to remove despite their more challenging characteristics, a multicenter study showed. The leads were removed ...

For the past two decades, catheter ablation stole most of the excitement in electrophysiology. Cardiac pacing was seen as necessary but boring. His-bundle pacing earned only modest attention. But at ...